“…The triglyceride-to-HDL cholesterol ratio has been investigated recently for various potential clinical uses in adult and paediatric populations (Di Bonito et al, 2012;He et al, 2012;Cordero et al, 2008;Musso et al, 2011;Zoppini et al, 2011;Gaziano et al, 1997;Giannini et al, 2011;Bittner et al, 2009;Li et al, 2008;Quijada et al, 2008;McLaughlin et al, 2003;Fan et al, 2007). Previous research has demonstrated its positive associations with adverse cardiometabolic risk factor profiles, metabolic syndrome and prediction of incident T2DM or its complications (Di Bonito et al, 2012;He et al, 2012;Cordero et al, 2008;Musso et al, 2011;Zoppini et al, 2011;Gaziano et al, 1997;Giannini et al, 2011;Bittner et al, 2009;Li et al, 2008;Quijada et al, 2008;McLaughlin et al, 2003;Fan et al, 2007).…”